{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:49Z","timestamp":1786993249380,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["YY-004"],"award-info":[{"award-number":["YY-004"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["020814380114"],"award-info":[{"award-number":["020814380114"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922067"],"award-info":[{"award-number":["81922067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730100"],"award-info":[{"award-number":["81730100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jphs.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:37:24Z","timestamp":1596487044000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds"],"prefix":"10.1016","volume":"144","author":[{"given":"Wenjie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5101","key":"10.1016\/j.jphs.2020.06.002_bib1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1126\/science.8096088","article-title":"SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases","volume":"259","author":"Feng","year":"1993","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.002_bib2","first-page":"6674","article-title":"Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation","volume":"14","author":"Noguchi","year":"1994","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.devcel.2010.03.009","article-title":"Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis","volume":"18","author":"Stewart","year":"2010","journal-title":"Dev Cell"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib4","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1074\/jbc.M112.397885","article-title":"Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2","volume":"288","author":"Yu","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.cr.7290055","article-title":"The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions","volume":"10","author":"Qu","year":"2000","journal-title":"Cell Res"},{"issue":"43","key":"10.1016\/j.jphs.2020.06.002_bib7","doi-asserted-by":"crossref","first-page":"41677","DOI":"10.1074\/jbc.M306461200","article-title":"Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors","volume":"278","author":"Araki","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1097-2765(01)00369-0","article-title":"Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling","volume":"8","author":"Lu","year":"2001","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.jphs.2020.06.002_bib9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng2078","article-title":"Germline gain-of-function mutations in RAF1 cause Noonan syndrome","volume":"39","author":"Razzaque","year":"2007","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.002_bib10","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","article-title":"PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience","volume":"41","author":"Keren","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2006-07-028829","article-title":"PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase","volume":"109","author":"Chan","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc1837","article-title":"Protein-tyrosine phosphatases and cancer","volume":"6","author":"Ostman","year":"2006","journal-title":"Nat Rev Canc"},{"issue":"7628","key":"10.1016\/j.jphs.2020.06.002_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nature20131","article-title":"Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment","volume":"539","author":"Dong","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm.2645","article-title":"Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop","volume":"18","author":"Aceto","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI43690","article-title":"SHP-2\/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A\/ARF aberrations in mice and humans","volume":"121","author":"Liu","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.28919","article-title":"Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients","volume":"65","author":"Xiang","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.002_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/onc.2015.184","article-title":"Shp2 promotes metastasis of prostate cancer by attenuating the PAR3\/PAR6\/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition","volume":"35","author":"Zhang","year":"2015","journal-title":"Oncogene"},{"issue":"43","key":"10.1016\/j.jphs.2020.06.002_bib18","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1038\/onc.2016.100","article-title":"SHP-2-upregulated ZEB1 is important for PDGFRalpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jphs.2020.06.002_bib19","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1038\/ncomms10420","article-title":"The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42","volume":"7","author":"Tien","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1073\/pnas.1508535113","article-title":"Gain-of-function mutations of Ptpn11 (Shp2) cause aberrant mitosis and increase susceptibility to DNA damage-induced malignancies","volume":"113","author":"Liu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"10.1016\/j.jphs.2020.06.002_bib21","doi-asserted-by":"crossref","first-page":"25727","DOI":"10.1074\/jbc.M113.462291","article-title":"Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence","volume":"288","author":"Zheng","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.002_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049943","article-title":"Novel functions of the phosphatase SHP2 in the DNA replication and damage checkpoints","volume":"7","author":"Tsang","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.002_bib23","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.celrep.2015.08.037","article-title":"PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs","volume":"12","author":"Prahallad","year":"2015","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.jphs.2020.06.002_bib24","doi-asserted-by":"crossref","first-page":"23664","DOI":"10.18632\/oncotarget.15641","article-title":"Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0167-4889(02)00322-1","article-title":"Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response","volume":"1592","author":"Qu","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.jphs.2020.06.002_bib26","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1128\/MCB.23.21.7875-7886.2003","article-title":"Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling","volume":"23","author":"Agazie","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.002_bib27","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1073\/pnas.1119803109","article-title":"Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature","volume":"109","author":"De Rocca Serra-Nedelec","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1128\/MCB.20.5.1526-1536.2000","article-title":"Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity","volume":"20","author":"Shi","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.002_bib29","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","article-title":"Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation","volume":"100","author":"Matozaki","year":"2009","journal-title":"Canc Sci"},{"issue":"7610","key":"10.1016\/j.jphs.2020.06.002_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nature18621","article-title":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases","volume":"535","author":"Chen","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jphs.2020.06.002_bib31","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/bph.12565","article-title":"Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice","volume":"171","author":"Luo","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI87037","article-title":"Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus","volume":"126","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1158\/0008-5472.CAN-14-1215","article-title":"PD-1\/SHP-2 inhibits Tc1\/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.jphs.2020.06.002_bib35","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.4049\/jimmunol.177.9.5990","article-title":"Conditional deletion of Shp2 tyrosine phosphatase in thymocytes suppresses both pre-TCR and TCR signals","volume":"177","author":"Nguyen","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib36","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ccr.2011.03.023","article-title":"Ptpn11\/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis","volume":"19","author":"Bard-Chapeau","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.immuni.2006.10.014","article-title":"SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production","volume":"25","author":"An","year":"2006","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.002_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20181198","article-title":"Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10","volume":"216","author":"Xiao","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"37","key":"10.1016\/j.jphs.2020.06.002_bib40","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1038\/s41388-018-0337-6","article-title":"Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-gamma production in tumor microenvironment","volume":"37","author":"Xiao","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.002_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02351-0","article-title":"Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jphs.2020.06.002_bib42","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jcmm.12618","article-title":"Functions of Shp2 in cancer","volume":"19","author":"Zhang","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.002_bib43","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejmg.2015.08.005","article-title":"SHP2 sails from physiology to pathology","volume":"58","author":"Tajan","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jphs.2020.06.002_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semcdb.2014.09.013","article-title":"The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease","volume":"37","author":"Lauriol","year":"2015","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib45","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2174\/1568009614666140717105001","article-title":"Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis","volume":"14","author":"Huang","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.002_bib46","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4155\/fmc.14.88","article-title":"Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention","volume":"6","author":"Butterworth","year":"2014","journal-title":"Future Med Chem"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11684-012-0216-4","article-title":"Dual faces of SH2-containing protein-tyrosine phosphatase Shp2\/PTPN11 in tumorigenesis","volume":"6","author":"Li","year":"2012","journal-title":"Front Med"},{"key":"10.1016\/j.jphs.2020.06.002_bib48","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.phrs.2019.104595","article-title":"Targeting SHP2 as a promising strategy for cancer immunotherapy","volume":"152","author":"Liu","year":"2020","journal-title":"Pharmacol Res"},{"issue":"38","key":"10.1016\/j.jphs.2020.06.002_bib49","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1038\/sj.onc.1206846","article-title":"Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling","volume":"22","author":"Yu","year":"2003","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.jphs.2020.06.002_bib50","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.4049\/jimmunol.1201006","article-title":"Selective sequestration of STAT1 in the cytoplasm via phosphorylated SHP-2 ameliorates murine experimental colitis","volume":"189","author":"Wu","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"49","key":"10.1016\/j.jphs.2020.06.002_bib51","doi-asserted-by":"crossref","first-page":"47572","DOI":"10.1074\/jbc.M207536200","article-title":"SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei","volume":"277","author":"Wu","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.002_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni886","article-title":"TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction","volume":"4","author":"Oshiumi","year":"2003","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.002_bib54","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1074\/jbc.272.2.1032","article-title":"Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases","volume":"272","author":"Yin","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.002_bib55","first-page":"1589","article-title":"Multiple in\u00a0vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584","volume":"7","author":"Vogel","year":"1996","journal-title":"Cell Growth Differ"},{"issue":"7","key":"10.1016\/j.jphs.2020.06.002_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3271","article-title":"Spotlight on the role of COP1 in tumorigenesis","volume":"12","author":"Marine","year":"2012","journal-title":"Nat Rev Canc"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bcp.2010.05.019","article-title":"Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112","volume":"80","author":"Chen","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"14","key":"10.1016\/j.jphs.2020.06.002_bib58","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.bmcl.2011.05.078","article-title":"Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening","volume":"21","author":"Yu","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.002_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chembiol.2010.10.015","article-title":"SHP2 is a target of the immunosuppressant tautomycetin","volume":"18","author":"Liu","year":"2011","journal-title":"Chem Biol"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.002_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1124\/mol.106.025536","article-title":"Discovery of a novel shp2 protein tyrosine phosphatase inhibitor","volume":"70","author":"Chen","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"20","key":"10.1016\/j.jphs.2020.06.002_bib61","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.0710468105","article-title":"Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking","volume":"105","author":"Hellmuth","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.jphs.2020.06.002_bib62","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1021\/jm5006176","article-title":"Therapeutic potential of targeting the oncogenic SHP2 phosphatase","volume":"57","author":"Zeng","year":"2014","journal-title":"J\u00a0Med Chem"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7164\/antibiotics.40.907","article-title":"A\u00a0new antibiotic, tautomycin","volume":"40","author":"Cheng","year":"1987","journal-title":"J\u00a0Antibiot (Tokyo)"},{"issue":"16","key":"10.1016\/j.jphs.2020.06.002_bib64","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.1073\/pnas.162522099","article-title":"Immunosuppressive effects of tautomycetin in\u00a0vivo and in\u00a0vitro via T cell-specific apoptosis induction","volume":"99","author":"Shim","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.002_bib65","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0041-1345(02)03905-2","article-title":"Tautomycetin as a novel immunosuppressant in transplantation","volume":"35","author":"Han","year":"2003","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.002_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/abio.1999.4202","article-title":"Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and beta-galactosidases","volume":"273","author":"Gee","year":"1999","journal-title":"Anal Biochem"},{"issue":"17","key":"10.1016\/j.jphs.2020.06.002_bib67","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","article-title":"Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor","volume":"59","author":"Garcia Fortanet","year":"2016","journal-title":"J\u00a0Med Chem"},{"issue":"24","key":"10.1016\/j.jphs.2020.06.002_bib68","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1021\/acs.jmedchem.7b01520","article-title":"Allosteric inhibitors of SHP2 with therapeutic potential for cancer treatment","volume":"60","author":"Xie","year":"2017","journal-title":"J\u00a0Med Chem"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.exphem.2006.02.014","article-title":"Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1","volume":"34","author":"Leng","year":"2006","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.002_bib70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7445","article-title":"Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling","volume":"5","author":"Frank","year":"1999","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jphs.2020.06.002_bib71","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-gamma signaling by glucocorticoids","volume":"170","author":"Hu","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib72","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.fitote.2011.04.002","article-title":"Chemical constituents from endophytic fungus Fusarium oxysporum","volume":"82","author":"Wang","year":"2011","journal-title":"Fitoterapia"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.002_bib73","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/jid.2014.252","article-title":"Trichomide A, a natural cyclodepsipeptide, exerts immunosuppressive activity against activated T lymphocytes by upregulating SHP2 activation to overcome contact dermatitis","volume":"134","author":"Wang","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.002_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2011.01.108","article-title":"A\u00a0novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2 (vol 21, pg 874, 2011)","volume":"21","author":"Bu","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jphs.2020.06.002_bib75","doi-asserted-by":"crossref","first-page":"24945","DOI":"10.1038\/srep24945","article-title":"Plasiatine, an unprecedented indole-phenylpropanoid hybrid from Plantago asiatica as a potent activator of the nonreceptor protein tyrosine phosphatase Shp2","volume":"6","author":"Gao","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2020.06.002_bib76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0079-6603(03)01006-7","article-title":"Mechanistic studies on protein tyrosine phosphatases","volume":"73","author":"Zhang","year":"2003","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.jphs.2020.06.002_bib77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2017.06.131","article-title":"Geranylnaringenin (CG902) inhibits constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase","volume":"142","author":"Jin","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"5555","key":"10.1016\/j.jphs.2020.06.002_bib78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1067147","article-title":"SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein","volume":"295","author":"Higashi","year":"2002","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.002_bib79","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.celrep.2017.08.080","article-title":"Differential mechanisms for SHP2 binding and activation are exploited by geographically distinct Helicobacter pylori CagA oncoproteins","volume":"20","author":"Hayashi","year":"2017","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.jphs.2020.06.002_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay4458","article-title":"Molecular mechanism of SHP2 activation by PD-1 stimulation","volume":"6","author":"Marasco","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jphs.2020.06.002_bib81","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA119.010838","article-title":"A\u00a0cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors","author":"Romero","year":"2020","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.002_bib82","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2015.03.036","article-title":"PTPN11\/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients","volume":"63","author":"Han","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"45","key":"10.1016\/j.jphs.2020.06.002_bib83","doi-asserted-by":"crossref","first-page":"73817","DOI":"10.18632\/oncotarget.12074","article-title":"SHP2 phosphatase as a novel therapeutic target for melanoma treatment","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132030058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S134786132030058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:00:32Z","timestamp":1761163232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S134786132030058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S134786132030058X"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2020.06.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}